The global Lennox-Gastaut Syndrome Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Lennox?Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3?5 years and can persist into adulthood.
This report aims to provide a comprehensive presentation of the global market for Lennox-Gastaut Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lennox-Gastaut Syndrome Treatment. This report contains market size and forecasts of Lennox-Gastaut Syndrome Treatment in global, including the following market information:
- Global Lennox-Gastaut Syndrome Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
We surveyed the Lennox-Gastaut Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lennox-Gastaut Syndrome Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, by Type, 2022 (%)
- Non-surgical Treatment
- Surgical Treatment
Global Lennox-Gastaut Syndrome Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, by Application, 2022 (%)
- Seizures
- Ocular Abnormality
- EEG Findings
- Others
Global Lennox-Gastaut Syndrome Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lennox-Gastaut Syndrome Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Lennox-Gastaut Syndrome Treatment revenues share in global market, 2022 (%)
Key players include:
- Eisai Co., Ltd.
- GlaxoSmithKline plc.
- H. Lundbeck A/S
- Johnson & Johnson Services, Inc.
- Supernus Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lennox-Gastaut Syndrome Treatment, market overview.
Chapter 2: Global Lennox-Gastaut Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Lennox-Gastaut Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lennox-Gastaut Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lennox-Gastaut Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lennox-Gastaut Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lennox-Gastaut Syndrome Treatment Overall Market Size
2.1 Global Lennox-Gastaut Syndrome Treatment Market Size: 2022 VS 2030
2.2 Global Lennox-Gastaut Syndrome Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lennox-Gastaut Syndrome Treatment Players in Global Market
3.2 Top Global Lennox-Gastaut Syndrome Treatment Companies Ranked by Revenue
3.3 Global Lennox-Gastaut Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Lennox-Gastaut Syndrome Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lennox-Gastaut Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lennox-Gastaut Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Lennox-Gastaut Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Lennox-Gastaut Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lennox-Gastaut Syndrome Treatment Market Size Markets, 2022 & 2030
4.1.2 Non-surgical Treatment
4.1.3 Surgical Treatment
4.2 By Type - Global Lennox-Gastaut Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Lennox-Gastaut Syndrome Treatment Revenue, 2018-2023
4.2.2 By Type - Global Lennox-Gastaut Syndrome Treatment Revenue, 2024-2030
4.2.3 By Type - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lennox-Gastaut Syndrome Treatment Market Size, 2022 & 2030
5.1.2 Seizures
5.1.3 Ocular Abnormality
5.1.4 EEG Findings
5.1.5 Others
5.2 By Application - Global Lennox-Gastaut Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Lennox-Gastaut Syndrome Treatment Revenue, 2018-2023
5.2.2 By Application - Global Lennox-Gastaut Syndrome Treatment Revenue, 2024-2030
5.2.3 By Application - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lennox-Gastaut Syndrome Treatment Market Size, 2022 & 2030
6.2 By Region - Global Lennox-Gastaut Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Lennox-Gastaut Syndrome Treatment Revenue, 2018-2023
6.2.2 By Region - Global Lennox-Gastaut Syndrome Treatment Revenue, 2024-2030
6.2.3 By Region - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030
6.3.2 US Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.3.3 Canada Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.3.4 Mexico Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030
6.4.2 Germany Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.3 France Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.4 U.K. Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.5 Italy Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.6 Russia Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.4.8 Benelux Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030
6.5.2 China Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.5.3 Japan Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.5.4 South Korea Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.5.6 India Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030
6.6.2 Brazil Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.6.3 Argentina Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030
6.7.2 Turkey Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.7.3 Israel Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
6.7.5 UAE Lennox-Gastaut Syndrome Treatment Market Size, 2018-2030
7 Lennox-Gastaut Syndrome Treatment Companies Profiles
7.1 Eisai Co., Ltd.
7.1.1 Eisai Co., Ltd. Company Summary
7.1.2 Eisai Co., Ltd. Business Overview
7.1.3 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Major Product Offerings
7.1.4 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Revenue in Global Market (2018-2023)
7.1.5 Eisai Co., Ltd. Key News & Latest Developments
7.2 GlaxoSmithKline plc.
7.2.1 GlaxoSmithKline plc. Company Summary
7.2.2 GlaxoSmithKline plc. Business Overview
7.2.3 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline plc. Key News & Latest Developments
7.3 H. Lundbeck A/S
7.3.1 H. Lundbeck A/S Company Summary
7.3.2 H. Lundbeck A/S Business Overview
7.3.3 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Major Product Offerings
7.3.4 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Revenue in Global Market (2018-2023)
7.3.5 H. Lundbeck A/S Key News & Latest Developments
7.4 Johnson & Johnson Services, Inc.
7.4.1 Johnson & Johnson Services, Inc. Company Summary
7.4.2 Johnson & Johnson Services, Inc. Business Overview
7.4.3 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Major Product Offerings
7.4.4 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.5 Supernus Pharmaceuticals, Inc
7.5.1 Supernus Pharmaceuticals, Inc Company Summary
7.5.2 Supernus Pharmaceuticals, Inc Business Overview
7.5.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Major Product Offerings
7.5.4 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Revenue in Global Market (2018-2023)
7.5.5 Supernus Pharmaceuticals, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lennox-Gastaut Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Lennox-Gastaut Syndrome Treatment Market Drivers in Global Market
Table 3. Lennox-Gastaut Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Lennox-Gastaut Syndrome Treatment in Global Market
Table 5. Top Lennox-Gastaut Syndrome Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lennox-Gastaut Syndrome Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lennox-Gastaut Syndrome Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lennox-Gastaut Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Lennox-Gastaut Syndrome Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lennox-Gastaut Syndrome Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Lennox-Gastaut Syndrome Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lennox-Gastaut Syndrome Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Lennox-Gastaut Syndrome Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lennox-Gastaut Syndrome Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Eisai Co., Ltd. Company Summary
Table 31. Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Product Offerings
Table 32. Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Eisai Co., Ltd. Key News & Latest Developments
Table 34. GlaxoSmithKline plc. Company Summary
Table 35. GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Product Offerings
Table 36. GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline plc. Key News & Latest Developments
Table 38. H. Lundbeck A/S Company Summary
Table 39. H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Product Offerings
Table 40. H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. H. Lundbeck A/S Key News & Latest Developments
Table 42. Johnson & Johnson Services, Inc. Company Summary
Table 43. Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Product Offerings
Table 44. Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Services, Inc. Key News & Latest Developments
Table 46. Supernus Pharmaceuticals, Inc Company Summary
Table 47. Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Product Offerings
Table 48. Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Supernus Pharmaceuticals, Inc Key News & Latest Developments
List of Figures
Figure 1. Lennox-Gastaut Syndrome Treatment Segment by Type in 2022
Figure 2. Lennox-Gastaut Syndrome Treatment Segment by Application in 2022
Figure 3. Global Lennox-Gastaut Syndrome Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lennox-Gastaut Syndrome Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Lennox-Gastaut Syndrome Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lennox-Gastaut Syndrome Treatment Revenue in 2022
Figure 8. By Type - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 16. US Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 28. China Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Lennox-Gastaut Syndrome Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Lennox-Gastaut Syndrome Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
